Monthly Archives: September 2023

Cardiovascular

Cardiovascular disease and all-cause mortality associated with individual and combined cardiometabolic risk factors

Posted on by yun
05
Sep

Study population China Hypertension Survey (CHS) is a nationally representative population-based study, which recruiting ~ 0.5 million participants from 31 provinces between October 2012 to December 2015 in mainland China. Design details were published previously [13,14,15]. This sub-study was based on CHS, and 16 cities and 17 counties were selected using a simple random sampling method from […]

Continue reading →
Congenital disorders

Function of a mutant ryanodine receptor (T4709M) linked to congenital myopathy

Posted on by yun
05
Sep

Abstract Physiological muscle contraction requires an intact ligand gating mechanism of the ryanodine receptor 1 (RyR1), the Ca2+-release channel of the sarcoplasmic reticulum. Some mutations impair the gating and thus cause muscle disease. The RyR1 mutation T4706M is linked to a myopathy characterized by muscle weakness. Although, low expression of the T4706M RyR1 protein can […]

Continue reading →
Cardiovascular

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study

Posted on by yun
05
Sep

Abstract We previously reported in the study of preventive effects of alogliptin on diabetic atherosclerosis (SPEAD-A) that alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, attenuated the progression of carotid atherosclerosis in subjects with type 2 diabetes and no history of cardiovascular disease. This extension study of the SPEAD-A trial investigated whether early alogliptin initiation improved long-term […]

Continue reading →
Congenital disorders

Chronic Pulmonary Hypertension Market is Likely to Increase at a Steady Growth Rate by 2032, Examines DelveInsight | Leading Companies – Attgeno, Cereno, Merck, Bellerophon, United Therapeutics, AbbVie, Tenax, Insmed

Posted on by yun
05
Sep

New York, USA, Sept. 05, 2023 (GLOBE NEWSWIRE) — Chronic Pulmonary Hypertension Market is Likely to Increase at a Steady Growth Rate by 2032, Examines DelveInsight | Leading Companies – Attgeno, Cereno, Merck, Bellerophon, United Therapeutics, AbbVie, Tenax, Insmed The chronic pulmonary hypertension market is anticipating the game changer in the market for the treatment […]

Continue reading →
Blood

‘Blood Battle’ between the Utah State Aggies and Weber State Wildcats starts today

Posted on by yun

FILE PHOTO: donating blood. Photo by Nguyễn Hiệp on Unsplash LOGAN – Football teams from the two schools won’t meet on the gridiron this year, but the annual “Blood Battle” between Utah State and Weber State continues for the 20th year, beginning Tuesday. This “competition” was created to support the American Red Cross in the […]

Continue reading →
Infection

Top in ID: Tough Mudder racers develop infections; renewed interest in West Nile vaccine

Posted on by yun
05
Sep

September 05, 2023 1 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. […]

Continue reading →
Cardiovascular

Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry

Posted on by yun
05
Sep

Abstract Aspirin may be considered for primary prevention in non-elderly patients with high cardiovascular risk. However, contemporary management aimed at aggressive cardiovascular risk factor control may alter benefit-risk ratio of aspirin. Therefore, we aimed to examine the effect of aspirin for primary prevention on the long-term MACEs in a large cohort registry. Cohort Of patients […]

Continue reading →
Cardiovascular

For better or worse: Wegovy’s latest trial highlights 3 clinical innovation trends

Posted on by yun

Wegovy’s latest trial results provide promising evidence that the weight-loss drug may help improve symptoms and physical function in patients with obesity and heart failure. Advisory Board‘s Rachael Peroutky and Kara Marlatt explain how this trial advances three trends in clinical innovation — for better or worse.  New trial finds Wegovy may benefit patients with […]

Continue reading →
Blood

Global Blood Warmer Devices Market Size to Reach USD 2.37 Billion in 2032

Posted on by yun

vancouver, Sept. 05, 2023 (GLOBE NEWSWIRE) — The global market for blood warmer devices is anticipated to achieve a market size of USD 2.37 billion by the year 2032. This growth is expected to follow a stable revenue Compound Annual Growth Rate (CAGR) of 8.5% throughout the forecast period, as outlined in the most recent […]

Continue reading →
Blood

Blood Culture Tests Market Set to Reach USD 7.6 Billion by 2028: Analyzing Drivers, Restraints, and Growth Opportunities

Posted on by yun

Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) — The “Global Blood Culture Tests Market by Method (Conventional, Automated), Product (Consumables, Instruments), Technology (Culture, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospitals, Reference Labs) & Region – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global blood culture tests market is projected to witness […]

Continue reading →